Frederic Caroff

CEO at Hephaistos Pharma

Speaker

Frederic is a Graduate of the Centrale school of engineering and ESSEC Business School. After nearly a decade in industrial engineering and management roles, he co-founded and led his first biotech company LPS-Biosciences, a Contract Research Organization working for large pharma companies in the field of infectious vaccines and diagnostics. In 2018, he created HEPHAISTOS-Pharma, a Franco-Belgian biotech company where he now serves as CEO.

At HEPHAISTOS, Frederic drives the company’s mission to develop the 3rd generation of Immune Engagers that can be injected intravenously, treating solid tumors and metastases. Under his leadership, the company raised over €10 million to select the lead candidate HEPHA-440 and prepare the GMP manufacturing. HEPHAISTOS is currently raising funds to support its clinical development.